Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male Also Known As Nicholas Virca
LinkedIn View on LinkedIn
Nick has played key roles in the management of biotechnology businesses focused on technology for human therapeutics, diagnostics and medical devices. He has a breadth of sales, marketing, development and general management expertise and the technical aptitude to turn vision into fruition in this dynamic industry.
Was the President and CEO of
HedgePath Pharmaceuticals, Inc., a biotech company focused on anti-cancer therapies
Former COO of a biosensor company where he guided development of products and technology in research and diagnostic markets
Previously had global responsibility for strategic expansion of biotechnology products and applications in a $900M division of a $2.6B public company
Co-founded four biotechnology companies
Raised tens of millions of dollars for six different healthcare companies
Launched over 50 products in the biopharmaceutical/medical device arena
Has been intimately involved in the strategy and conduct of clinical trials
Was awarded millions of dollars in government contracts for scientific product development and testing
Reversed two failing medical device businesses
Led sales management and training activities for pharmaceuticals and medical devices in four different leading-edge companies
Developed numerous licensing and distribution contracts in the US and Europe for pharmaceuticals, medical devices and reagents
Co-invented patented technology for molecular biology reagents and co-authored three US patents for anticancer therapy
Developed 22 cell culture manufacturing contracts with biopharmaceutical companies
Landed major government contracts for detection systems in the US, Latin America and the Middle East
Achieved number 1 position of 400 representatives selling adult nutritional products
Specialties: Business development, product management, licensing, M&A activities; therapeutics, medical devices, diagnostics
